{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:12:34Z","timestamp":1791339154572,"version":"4.3.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T00:00:00Z","timestamp":1107388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2005,2,3]],"date-time":"2005-02-03T00:00:00Z","timestamp":1107388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>Epstein-Barr virus (EBV) latently infects about 90% of the human population and is associated with benign and malignant diseases of lymphoid and epithelial origin. BHRF1, an early lytic cycle antigen, is an apoptosis suppressing member of the Bcl-2 family. <jats:italic>In vitro<\/jats:italic> studies imply that BHRF1 is dispensable for both virus replication and transformation. However, the fact that BHRF1 is highly conserved not only in all EBV isolates studied to date but also in the analogous viruses <jats:italic>Herpesvirus papio<\/jats:italic> and <jats:italic>Herpesvirus pan<\/jats:italic> that infect baboons and chimpanzees respectively, suggests BHRF1 may play an important role <jats:italic>in vivo<\/jats:italic>.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p><jats:italic>Herpesvirus papio<\/jats:italic> BHRF1 has been shown to function in an analogous manner to EBV BHRF1 in response to DNA damaging agents in human keratinocytes. In this study we show that the heterologous expression of the previously uncharacterised <jats:italic>Herpesvirus pan<\/jats:italic> BHRF1 in the human Burkitt's lymphoma cell line Ramos-BL provides similar anti-apoptotic functions to that of EBV BHRF1 in response to apoptosis triggered by serum withdrawal, etoposide treatment and ultraviolet (UV) radiation. We also map the amino acid changes onto the recently solved structure of the EBV BHRF1 and reveal that these changes are unlikely to alter the 3D structure of the protein.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>These findings show that the functional conservation of BHRF1 extends to a lymphoid background, suggesting that the primate virus proteins interact with cellular proteins that are themselves highly conserved across the higher primates. Further weight is added to this suggestion when we show that the difference in amino acid sequences map to regions on the 3D structure of EBV BHRF1 that are unlikely to change the conformation of the protein.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1471-2180-5-6","type":"journal-article","created":{"date-parts":[[2005,2,4]],"date-time":"2005-02-04T07:39:15Z","timestamp":1107502755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2"],"prefix":"10.1186","volume":"5","author":[{"given":"Melanie","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila A","family":"Hazlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,3]]},"reference":[{"key":"153_CR1","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2000","unstructured":"Hengartner MO: The biochemistry of apoptosis. Nature. 2000, 407: 770-776. 10.1038\/35037710.","journal-title":"Nature"},{"key":"153_CR2","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1038\/sj.onc.1202586","volume":"17","author":"A Bergmann","year":"1998","unstructured":"Bergmann A, Agapite J, Steller H: Mechanisms and control of programmed cell death in invertebrates. Oncogene. 1998, 17: 3215-3223. 10.1038\/sj.onc.1202586.","journal-title":"Oncogene"},{"key":"153_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1369-5274(02)00345-4","volume":"5","author":"F Tufaro","year":"2002","unstructured":"Tufaro F: Host-microbe interactions:viruses Viral strategies for breaching host defences: tipping the balance towards survival. Curr Opin in Microbiol. 2002, 5: 393-394. 10.1016\/S1369-5274(02)00345-4.","journal-title":"Curr Opin in Microbiol"},{"key":"153_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev.micro.53.1.577","volume":"53","author":"A Roulston","year":"1999","unstructured":"Roulston A, Marcellus RC, Branton PE: Viruses and apoptosis. Ann Rev Microbiol. 1999, 53: 577-628. 10.1146\/annurev.micro.53.1.577.","journal-title":"Ann Rev Microbiol"},{"key":"153_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/349612a0","volume":"349","author":"CD Gregory","year":"1991","unstructured":"Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 1991, 349: 612-614. 10.1038\/349612a0.","journal-title":"Nature"},{"key":"153_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/mp.53.5.219","volume":"53","author":"PG Murray","year":"2000","unstructured":"Murray PG, Young LS: Themed issue: the biology and pathology of the Epstein-Barr virus. Mol Pathol. 2000, 53: 219-221. 10.1136\/mp.53.5.219.","journal-title":"Mol Pathol"},{"key":"153_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/mp.52.6.307","volume":"52","author":"KRN Baumforth","year":"1999","unstructured":"Baumforth KRN, Young LS, Flavell KJ, Constandinou C, Murray PG: The Epstein-Barr virus and its association with human cancers. Mol Pathol. 1999, 52: 307-322.","journal-title":"Mol Pathol"},{"key":"153_CR8","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/0092-8674(91)90007-L","volume":"65","author":"S Henderson","year":"1991","unstructured":"Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A: Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death. Cell. 1991, 65: 1107-1115. 10.1016\/0092-8674(91)90007-L.","journal-title":"Cell"},{"key":"153_CR9","doi-asserted-by":"crossref","first-page":"24157","DOI":"10.1016\/S0021-9258(18)35741-7","volume":"267","author":"CD Laherty","year":"1992","unstructured":"Laherty CD, Hu HM, Opipari AW, Wang F, Dixit VM: Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J Biol Chem. 1992, 267: 24157-24160.","journal-title":"J Biol Chem"},{"key":"153_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/jvi.47.1.193-201.1983","volume":"47","author":"GR Pearson","year":"1983","unstructured":"Pearson GR, Vroman B, Chase B, Sculley T, Hummel M, Kieff E: Identification of polypeptide components of the Epstein-Barr virus early antigen complex using monoclonal antibodies. J Virol. 1983, 47: 193-201.","journal-title":"J Virol"},{"key":"153_CR11","doi-asserted-by":"publisher","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","volume":"90","author":"S Henderson","year":"1993","unstructured":"Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A: Epstein-Barr virus-coded BHRF-1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA. 1993, 90: 8479-8483.","journal-title":"Proc Natl Acad Sci USA"},{"key":"153_CR12","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1128\/jvi.76.5.2469-2479.2002","volume":"76","author":"DS Bellows","year":"2002","unstructured":"Bellows DS, Howell M, Pearson C, Hazlewood SA, Hardwick JM: Epstein-Barr virus BALF1 is a BCL-2-iike antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol. 2002, 76: 2469-2479. 10.1128\/jvi.76.5.2469-2479.2002.","journal-title":"J Virol"},{"key":"153_CR13","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1128\/JVI.73.6.5181-5185.1999","volume":"73","author":"WL Marshall","year":"1999","unstructured":"Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K, Williams L, Fingeroth J, Finberg RW: Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol. 1999, 73: 5181-5185.","journal-title":"J Virol"},{"key":"153_CR14","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1038\/sj.cdd.4401133","volume":"10","author":"JM Hardwick","year":"2003","unstructured":"Hardwick JM, Bellows DS: Virus versus cellular BCL-2 proteins. Cell Death Diff. 2003, 10: S68-S76. 10.1038\/sj.cdd.4401133.","journal-title":"Cell Death Diff"},{"key":"153_CR15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1128\/jvi.66.4.1899-1906.1992","volume":"66","author":"M-A Lee","year":"1992","unstructured":"Lee M-A, Yates JL: BHRF-1 of Epstein-Barr virus, which is homologous to the human proto-oncogene bcl-2, is not essential for transformation of B-cell or for virus replication in vitro. J Virol. 1992, 66: 1899-1906.","journal-title":"J Virol"},{"key":"153_CR16","doi-asserted-by":"crossref","first-page":"5991","DOI":"10.1128\/jvi.65.11.5991-6000.1991","volume":"65","author":"A Marchini","year":"1991","unstructured":"Marchini A, Tomkinson B, Cohen JI, Kieff E: BHRF-1, the Epstein-Barr virus gene with homology to Bcl-2, is dispensible for B lymphocyte transformation and virus replication. J Virol. 1991, 65: 5991-6000.","journal-title":"J Virol"},{"key":"153_CR17","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1099\/0022-1317-78-11-2987","volume":"78","author":"F Khanim","year":"1997","unstructured":"Khanim F, Dawson C, Meseda CA, Dawson J, Mackett M, Young LS: BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates. J Gen Virol. 1997, 78: 2987-2999.","journal-title":"J Gen Virol"},{"key":"153_CR18","first-page":"69","volume":"10","author":"CW Dawson","year":"1995","unstructured":"Dawson CW, Eliopoulos AG, Dawson J, Young LS: BHRF1, a viral homolog of the bcl-2 oncogene, disturbs epithelial-cell differentiation. Oncogene. 1995, 10: 69-77.","journal-title":"Oncogene"},{"key":"153_CR19","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood.V86.5.1893.bloodjournal8651893","volume":"86","author":"JJ Oudejans","year":"1995","unstructured":"Oudejans JJ, van den Brule AJC, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JMM, Meijer CJLM: BHRF1, the Epstein Barr virus (EBV) homolgue of the Bcl-2 proto-oncogene, is transcribed in EBV-associated B-cel lymphomas and in reactive lymphocyte. Blood. 1995, 86: 1893-1902.","journal-title":"Blood"},{"key":"153_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1054\/bjoc.2000.1687","volume":"84","author":"ZG Xu","year":"2001","unstructured":"Xu ZG, Iwatsuki K, Oyama N, Ohtsuka M, Satoh M, Kikuchi S, Akiba H, Kaneko F: The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer\/T-cell lymphomas. Br J Cancer. 2001, 84: 920-925. 10.1054\/bjoc.2000.1687.","journal-title":"Br J Cancer"},{"key":"153_CR21","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1073\/pnas.85.11.3678","volume":"85","author":"PJ Austin","year":"1988","unstructured":"Austin PJ, Flemington E, Yandava CN, Strominger JL, Speck SH: Complex transcription of the EBV Bam HI fragment H rightward open-reading frame 1 (BHRF-1) in latently and lytically infected B-lymphocytes. Proc Natl Acad Sci USA. 1988, 85: 3678-3682.","journal-title":"Proc Natl Acad Sci USA"},{"key":"153_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4899-0274-0_9","volume":"406","author":"NJ McCarthy","year":"1996","unstructured":"McCarthy NJ, Hazlewood SA, Huen DS, Rickinson AB, Williams GT: The Epstein-Barr virus gene BHRF1, a homologue of the cellular Bcl-2 oncogene bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs. Adv Exp Med Biol. 1996, 406: 83-97.","journal-title":"Adv Exp Med Biol"},{"key":"153_CR23","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1128\/jvi.71.10.7509-7517.1997","volume":"71","author":"L Foghsgaard","year":"1997","unstructured":"Foghsgaard L, Jaattela M: The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J Virol. 1997, 71: 7509-7517.","journal-title":"J Virol"},{"key":"153_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000050031","volume":"44","author":"T Williams","year":"2001","unstructured":"Williams T, Sale D, Hazlewood SA: BHRF1 is highly conserved in primate analogues of Epstein-Barr virus. Intervirology. 2001, 44: 55-58. 10.1159\/000050031.","journal-title":"Intervirology"},{"key":"153_CR25","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1099\/0022-1317-81-7-1801","volume":"81","author":"CA Meseda","year":"2000","unstructured":"Meseda CA, Arrand JR, Mackett M: Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1. J Gen Virol. 2000, 81: 1801-1805.","journal-title":"J Gen Virol"},{"key":"153_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jmb.2003.08.007","volume":"332","author":"Q Huang","year":"2003","unstructured":"Huang Q, Petros AM, Virgin H, Fesik SW, Olejniczak ET: Solution structure of BHRF-1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J Mol Biol. 2003, 332: 1123-1130. 10.1016\/j.jmb.2003.08.007.","journal-title":"J Mol Biol"},{"key":"153_CR27","doi-asserted-by":"publisher","first-page":"27354","DOI":"10.1074\/jbc.M103821200","volume":"276","author":"L-Y Li","year":"2001","unstructured":"Li L-Y, Shih H-M, Liu M-Y, Chen J-Y: The cellular protein PRA1 mediates the antiapoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem. 2001, 276: 27354-27362. 10.1074\/jbc.M103821200.","journal-title":"J Biol Chem"},{"key":"153_CR28","first-page":"1921","volume":"11","author":"JM Boyd","year":"1995","unstructured":"Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ: Bik, a novel death-inducing protein shares a distinct sequence motif with bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 1995, 11: 1921-1928.","journal-title":"Oncogene"},{"key":"153_CR29","doi-asserted-by":"publisher","first-page":"12401","DOI":"10.1073\/pnas.94.23.12401","volume":"94","author":"SY Hsu","year":"1997","unstructured":"Hsu SY, Kaipia A, McGee E, Lomeli M, Hsueh AJW: Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc Natl Acad Sci U S A. 1997, 94: 12401-12406. 10.1073\/pnas.94.23.12401.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-5-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1471-2180-5-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-5-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:09:55Z","timestamp":1728306595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/1471-2180-5-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2005,12]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1186\/1471-2180-5-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,3]]},"assertion":[{"value":"23 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}